Alexander Y Walley1,2, Dana Bernson2, Marc R Larochelle1, Traci C Green3, Leonard Young2, Thomas Land4. 1. Department of Medicine, Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Boston University School of Medicine & Boston Medical Center, Boston, MA, USA. 2. Massachusetts Department of Public Health, Boston, MA, USA. 3. Department of Emergency Medicine, Injury Prevention Center, Boston University School of Medicine & Boston Medical Center, Boston, MA, USA. 4. Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
Abstract
OBJECTIVES: Opioid-related overdoses are commonly attributed to prescription opioids. We examined data on opioid-related overdose decedents in Massachusetts. For each decedent, we determined which opioid medications had been prescribed and dispensed and which opioids were detected in postmortem medical examiner toxicology specimens. METHODS: Among opioid-related overdose decedents in Massachusetts during 2013-2015, we analyzed individually linked postmortem opioid toxicology reports and prescription drug monitoring program records to determine instances of overdose in which a decedent had a prescription active on the date of death for the opioid(s) detected in the toxicology report. We also calculated the proportion of overdoses for which prescribed opioid medications were not detected in decedents' toxicology reports. RESULTS: Of 2916 decedents with complete toxicology reports, 1789 (61.4%) had heroin and 1322 (45.3%) had fentanyl detected in postmortem toxicology reports. Of the 491 (16.8%) decedents with ≥1 opioid prescription active on the date of death, prescribed opioids were commonly not detected in toxicology reports, specifically: buprenorphine (56 of 97; 57.7%), oxycodone (93 of 176; 52.8%), and methadone prescribed for opioid use disorder (36 of 112; 32.1%). Only 39 (1.3%) decedents had an active prescription for each opioid detected in toxicology reports on the date of death. CONCLUSION: Linking overdose toxicology reports to prescription drug monitoring program records can help attribute overdoses to prescribed opioids, diverted prescription opioids, heroin, and illicitly made fentanyl.
OBJECTIVES: Opioid-related overdoses are commonly attributed to prescription opioids. We examined data on opioid-related overdose decedents in Massachusetts. For each decedent, we determined which opioid medications had been prescribed and dispensed and which opioids were detected in postmortem medical examiner toxicology specimens. METHODS: Among opioid-related overdose decedents in Massachusetts during 2013-2015, we analyzed individually linked postmortem opioid toxicology reports and prescription drug monitoring program records to determine instances of overdose in which a decedent had a prescription active on the date of death for the opioid(s) detected in the toxicology report. We also calculated the proportion of overdoses for which prescribed opioid medications were not detected in decedents' toxicology reports. RESULTS: Of 2916 decedents with complete toxicology reports, 1789 (61.4%) had heroin and 1322 (45.3%) had fentanyl detected in postmortem toxicology reports. Of the 491 (16.8%) decedents with ≥1 opioid prescription active on the date of death, prescribed opioids were commonly not detected in toxicology reports, specifically: buprenorphine (56 of 97; 57.7%), oxycodone (93 of 176; 52.8%), and methadone prescribed for opioid use disorder (36 of 112; 32.1%). Only 39 (1.3%) decedents had an active prescription for each opioid detected in toxicology reports on the date of death. CONCLUSION: Linking overdose toxicology reports to prescription drug monitoring program records can help attribute overdoses to prescribed opioids, diverted prescription opioids, heroin, and illicitly made fentanyl.
Entities:
Keywords:
fentanyl; heroin; overdose; prescription drug monitoring programs; prescription opioids
Authors: Melissa C Mercado; Steven A Sumner; M Bridget Spelke; Michele K Bohm; David E Sugerman; Christina Stanley Journal: Pain Med Date: 2018-03-01 Impact factor: 3.750
Authors: Dayong Lee; Chris W Chronister; Wilson A Broussard; Suzanne R Utley-Bobak; Daniel L Schultz; Russell S Vega; Bruce A Goldberger Journal: J Anal Toxicol Date: 2016-10 Impact factor: 3.367
Authors: Roneet Lev; Sean Petro; Oren Lee; Jonathan Lucas; Amy Stuck; Gary M Vilke; Edward M Castillo Journal: Am J Emerg Med Date: 2015-12-14 Impact factor: 2.469
Authors: Leonard J Paulozzi; Joseph E Logan; Aron J Hall; Edna McKinstry; James A Kaplan; Alexander E Crosby Journal: Addiction Date: 2009-09 Impact factor: 6.526
Authors: Alexander Y Walley; Dana Bernson; Marc R Larochelle; Traci C Green; Leonard Young; Thomas Land Journal: Public Health Rep Date: 2020-07-02 Impact factor: 2.792
Authors: Shayla Nolen; Xiao Zang; Avik Chatterjee; Czarina N Behrends; Traci C Green; Aranshi Kumar; Benjamin P Linas; Jake R Morgan; Sean M Murphy; Alexander Y Walley; Shapei Yan; Bruce R Schackman; Brandon D L Marshall Journal: Addiction Date: 2021-12-05 Impact factor: 7.256
Authors: Sarah A Palumbo; Kayleigh M Adamson; Sarathbabu Krishnamurthy; Shivani Manoharan; Donielle Beiler; Anthony Seiwell; Colt Young; Raghu Metpally; Richard C Crist; Glenn A Doyle; Thomas N Ferraro; Mingyao Li; Wade H Berrettini; Janet D Robishaw; Vanessa Troiani Journal: JAMA Netw Open Date: 2020-09-01